| Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib D Ghez, A Calleja, C Protin, M Baron, MP Ledoux, G Damaj, M Dupont, ... Blood, The Journal of the American Society of Hematology 131 (17), 1955-1959, 2018 | 291 | 2018 |
| Early discontinuation of empirical antibacterial therapy in febrile neutropenia: the ANTIBIOSTOP study L Le Clech, JP Talarmin, MA Couturier, JC Ianotto, C Nicol, R Le Calloch, ... Infectious Diseases 50 (7), 539-549, 2018 | 75 | 2018 |
| Subcutaneous rituximab-MiniCHOP compared with subcutaneous rituximab-MiniCHOP plus lenalidomide in diffuse large B-cell lymphoma for patients age 80 years or older L Oberic, F Peyrade, M Puyade, C Bonnet, P Dartigues-Cuillères, ... Journal of Clinical Oncology 39 (11), 1203-1213, 2021 | 68 | 2021 |
| Bendamustine plus rituximab in newly‐diagnosed Waldenström macroglobulinaemia patients. A study on behalf of the French Innovative Leukaemia Organization (FILO). K Laribi, S Poulain, L Willems, F Merabet, R Le Calloch, JR Eveillard, ... British Journal of Haematology 186 (1), 2019 | 60 | 2019 |
| Blastic plasmacytoid dendritic cell neoplasms: results of an international survey on 398 adult patients K Laribi, A Baugier de Materre, M Sobh, L Cerroni, CG Valentini, T Aoki, ... Blood Advances 4 (19), 4838-4848, 2020 | 55 | 2020 |
| French Innovative Leukemia Organization (FILO) CLL group. Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib D Ghez, A Calleja, C Protin, M Baron, MP Ledoux, G Damaj, M Dupont, ... Blood 131 (17), 1955-1959, 2018 | 41 | 2018 |
| Experience (1 year) of G-CSF biosimilars in PBSCT for lymphoma and myeloma patients JC Ianotto, A Tempescul, X Yan, P Delepine, R Le Calloch, E Hardy, ... Bone marrow transplantation 47 (6), 874-876, 2012 | 24 | 2012 |
| Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial X Leleu, C Hulin, J Lambert, A Bobin, A Perrot, L Karlin, M Roussel, ... Nature Medicine, 1-7, 2024 | 23 | 2024 |
| Outcome of Ph negative myeloproliferative neoplasms transforming to accelerated or leukemic phase LM Mollard, A Chauveau, F Boyer-Perrard, N Douet-Guilbert, R Houot, ... Leukemia & Lymphoma 59 (12), 2812-2820, 2018 | 21 | 2018 |
| Cerebral aspergillosis: An emerging opportunistic infection in patients receiving ibrutinib for chronic lymphocytic leukemia? E Gaye, A Le Bot, JP Talarmin, R Le Calloch, S Belaz, M Dupont, ... Médecine et Maladies Infectieuses 48 (4), 294-297, 2018 | 15 | 2018 |
| Diagnosis and prognosis are supported by integrated assessment of next-generation sequencing in chronic myeloid malignancies. A real-life study S Vantyghem, P Peterlin, S Thépot, A Ménard, V Dubruille, C Debord, ... Haematologica 106 (3), 701, 2020 | 14 | 2020 |
| Dose-intensity impacts on survival of adolescents and young adults with acute lymphoblastic leukemia treated in adult departments by a pediatric protocol (FRALLE 2000BT) T Cluzeau, N Dhedin, F Huguet, E Raffoux, S Maury, L Mannone, ... Blood, The Journal of the American Society of Hematology 120 (21), 3561-3561, 2012 | 14 | 2012 |
| Real-world study of the efficacy and safety of belantamab mafodotin (GSK2857916) in relapsed or refractory multiple myeloma based on data from the nominative ATU in France: the … A Talbot, A Bobin, L Tabone, J Lambert, C Boccaccio, C Deal, MO Petillon, ... Haematologica 108 (10), 2774, 2023 | 11* | 2023 |
| Aquagenic pruritus in essential thrombocythemia is associated with a higher risk of thrombosis C Le Gall‐Ianotto, R Le Calloch, MA Couturier, A Chauveau, E Lippert, ... Journal of Thrombosis and Haemostasis 17 (11), 1950-1955, 2019 | 11 | 2019 |
| Non-adherence to treatment with cytoreductive and/or antithrombotic drugs is frequent and associated with an increased risk of complications in patients with polycythemia vera … R Le Calloch, K Lacut, C Le Gall-Ianotto, E Nowak, M Abiven, ... haematologica 103 (4), 607, 2017 | 11 | 2017 |
| Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA group R Aubrais, K Bouabdallah, L Chartier, C Herbaux, A Banos, P Brice, ... Blood Advances 7 (19), 5733-5742, 2023 | 10 | 2023 |
| Aplastic anemia related to thymoma: a survey on behalf of the French reference center of aplastic anemia and a review of the literature N Gendron, FS de Fontbrune, A Guyard, J Fadlallah, S Chantepie, ... haematologica 105 (7), e333, 2020 | 8 | 2020 |
| Lymphomas with kidney involvement: the French multicenter retrospective LyKID study M Kohn, A Karras, M Zaidan, C Bénière, JB De Freminville, K Laribi, ... Leukemia & lymphoma 61 (4), 887-895, 2020 | 7 | 2020 |
| Hemorrhagic Cystitis due to BK Reactivation in a Young Female Treated for Hodgkin‐Disease R Le Calloch, JC Ianotto, C Berthou, A Tempescul Case Reports in Hematology 2011 (1), 592470, 2011 | 7 | 2011 |
| Therapy-related myeloid neoplasms in patients with chronic lymphocytic leukemia who received FCR/FC as frontline therapy K Laribi, AB de Materre, D Ghez, C Dartigeas, C Tomowiak, B Mahé, ... Hemasphere 6 (6), e716, 2022 | 6 | 2022 |
